(Q44158873)

English

Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kazuaki Chayama

8

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

6

object named as

Michio Imamura

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

object named as

Hiroshi Aikata

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Yoshiiku Kawakami

4

object named as

Yoshiiku Kawakami

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Koji Kamada

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mikiya Kitamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Hirotaka Kono

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Toshio Nakanishi

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

The American Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

184

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

284-290

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Surgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Evaluation of surgical resection for small hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Surgical resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Partial hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Significance of tumor vascularity as a predictor of long-term prognosis in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Radiofrequency ablation for unresectable hepatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900933-9

7 January 2021

Identifiers

10.1016/S0002-9610(02)00933-9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44158873&oldid=2107274418"